Clinically Meaningful Influenza and SARS-CoV-2 Vaccine Responses Following Treatment-Free Window of Obexelimab in patients with IgG4-RD (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2612; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Infectious Disease • Inflammation • Influenza • Novel Coronavirus Disease • Respiratory Diseases
|